“Hope and promise of precision medicine in infectious diseases”.
Our team was pleased to discuss your projects in #infectiousdiseases. A nice opportunity for us to share our capabilities in infectious & respiratory diseases and further details on our SARS-CoV-2 NHP model to assess immunotherapies, vaccines and antivirals.
🔸 Biofortis and Active Biomarkers, partners of Cynbiome (preclinical network of excellence for microbiota and infectious diseases) was also exhibiting. A unique opportunity to discuss how we can support the preclinical of human microbiome-based therapeutics and drug candidates!